Clinical Trials Browser

Phase 1/2 × OTHER × trastuzumab deruxtecan × Clear all

NCT06085755 2025-12-15

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT07134153 2025-08-21

INOVATE

Phase 1/2 Recruiting

Breast Neoplasms

NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms